Navigation Links
Chiltern and EPS INTERNATIONAL Enter Into a Global Partnership

LONDON and TOKYO, June 23 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global Clinical Research Organization (CRO) that provides clinical development and staffing services in Europe, North America, Latin America and India today announced that it had entered into a global partnership agreement with EPS International Co., Ltd. (EPS INTERNATIONAL), a wholly owned subsidiary of EPS Co., Ltd., a leading provider of a clinical development services in the Asian region.

Chiltern will provide services to EPS INTERNATIONAL from their network of offices in 23 countries throughout Europe, North America, South America and India. Similarly, EPS INTERNATIONAL will provide clinical development services for the Asian region from their offices in Japan, China, Singapore, Korea and Taiwan.

"We are pleased to have entered into a partnership with EPS INTERNATIONAL," said Glenn Kerkhof, CEO of Chiltern. "Asia is becoming an increasingly attractive market for clinical trial services and finding a partner with a meaningful presence and experience of conducting clinical trials throughout Southeast Asia is an important development for Chiltern. With EPS as our partner in this region we continue to focus on our mission to deliver expert, high quality, clinical development services around the world."

"We are delighted to have signed a partnership agreement with Chiltern," commented Dr. Tatsuhiko Ichiki, President & CEO of EPS INTERNATIONAL. "The core of our business has been in Asia and an increased demand for global trials outside of the region has made the timing for this partnership good. EPS and Chiltern have similar business philosophies and are both well regarded for the quality of their clinical services and personnel. With this partnership, we will be in a position to offer our sponsors an increased international reach while maintaining the high quality of services our sponsors have come to expect from EPS."

About Chiltern:

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. Chiltern employs more than 1200 people with 23 offices across the United States, Europe, Latin America and in India. Chiltern provides services including Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Further information is available at

About EPS International:

EPS International Co., Ltd. (EPS INTERNATIONAL), a wholly owned subsidiary of EPS Co., Ltd. (EPS), a public company on the First Section of Tokyo Stock Exchange, in Tokyo, Japan, commenced its operations in April 2007. EPS INTERNATIONAL is headquartered in Tokyo, Japan and provides clinical research and development platform services throughout the Asian region. EPS INTERNATIONAL is fully supported by a team of high caliber, diligent and dedicated clinical professionals having many years of experience managing large- and small-scale, global and local clinical trials, from first-in-man to post marketing study for new chemical entities, biologics and medical devices. Further information is available at

For More Information Contact:

Chiltern Contact:

Ms. Catherine Lemercier Mr. Richard Baptista

Chiltern Chiltern

(1) 760 707 5025 (44) 1753 216 618

EPS International Contact:

Ms. Pey Ni Chan Mr. Hideki Koga

Singapore Tokyo

(65) 6294 1678 (81) 3 5225 7971

SOURCE Chiltern
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Chiltern Enhances Its Portfolio of Electronic Data Capture (EDC) Services With the Addition of Hosting and eCRF Design Services for DataLabs (by ClinPhone) and Medidata Rave(R) Certification
2. Chiltern Expands Its Global Reach to Latin America
3. Chiltern Announces New Expansion in Portugal
4. Chiltern Opens a New Office in Russia
5. Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CROs Meeting in Las Vegas, April 14 - 16, 2008.
6. Chiltern Wins Top Prize
7. Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS)
8. Diana Hatsis of Chiltern Will Present at the Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) 35th Annual Continuing Education Program Held in Conjunction With the American Academy of Ophthalmology (AAO) Annual Meeting
9. Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam
10. Chiltern Announces Acquisition of an Independent USA Based Clinical Research Organization, Clinical Trial Management Services, Inc.
11. Chiltern Appoints Steve Albrecht to Support Further Expansion in Late Phase
Post Your Comments:
(Date:12/1/2015)... ... 2015 , ... The Multiple System Atrophy Coalition has announced the launch of ... (MSA) research, timed today to coincide with Giving Tuesday 2015, a global day of ... to work and be productive, to do simple daily activities like walking to the ...
(Date:12/1/2015)... ... ... Royal River Natural Foods — a locally-owned, independent natural health store in ... nutritional supplement creatine, along with resistance training for a year, had more new bone ... report is part of the December 2015 issue of Natural Insights for Well Being®, ...
(Date:12/1/2015)... ... December 01, 2015 , ... Baptist Medical Center ... and is the only hospital in the region providing what is known as ... transcatheter pacing patients were revealed recently at a medical conference and published in ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015 -- InstantLabs ... company’s growing product line of food safety and seafood fraud prevention tools. , ... – allow InstantLabs to offer fast, reliable species identification for the four most ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic foot wounds ... Podiatrists are well aware that psychology-based patient non-compliance (disobedience of a health care ... to diseases of the diabetic foot. The American Board of Multiple Specialties ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 01, 2015 ... the "Medium Molecular Weight Polyisobutylene Market ... Other Applications - Global Industry Analysis, Size, ... 2023" report to their offering. ... addition of the "Medium Molecular Weight ...
(Date:12/1/2015)... CLEVELAND , Dec. 1, 2015   ... innovation firm, today announced the publication of a ... Entering the Direct-to-Consumer Medical Market". The whitepaper gives ... roadmap for successfully penetrating this lucrative segment. ... purchase healthcare products to manage their own health, ...
(Date:12/1/2015)... 1, 2015 Array BioPharma Inc. ... its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public ... through a webcast on the Array BioPharma ... --> , ...
Breaking Medicine Technology: